Bristol-Myers Squibb Company
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 27.3% | 12.1% | 8.4% |
| FY2024 | -54.8% | -14.0% | -9.7% |
| FY2025 | 38.2% | 11.5% | 7.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 27.3% | 12.1% | 8.4% |
| FY2024 | -54.8% | -14.0% | -9.7% |
| FY2025 | 38.2% | 11.5% | 7.8% |